ALPHANOSOS

Alphanosos discovers with its Artificial Intelligence based methodology, develops and commercializes actives and products based on edible plant extracts in the fields of animal hygiene and nutrition, derma-cosmetics and at longer term, functional foods and treatments to dislodge persistent bacterial communities present at the surface of organs and in cells, and which are often resistant to antibiotics and to the immune response, and finally, cancer prevention and curative treatments. Its patent-pending discoveries are incorporated into commercial products and generate its first revenues.